<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8" />
    <meta
      name="viewport"
      content="width=device-width, initial-scale=1"
    />
    <title>ASGARD PHARMA</title>
    <meta
      name="description"
      content="Fabless Biologics & Vaccine Manufacturing"
    />
    <link
      rel="icon"
      href="img/logo.svg"
    />
    <link
      rel="preconnect"
      href="https://fonts.gstatic.com"
      crossorigin
    />
    <link
      href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap"
      rel="stylesheet"
    />
    <link
      rel="stylesheet"
      href="css/asPharmaStyles.css"
    />
  </head>

  <body>
    <!-- Top notice / optional -->
    <div class="notice">
      <p><strong>Now onboarding specialty practices</strong> â€” join the early access program.</p>
      <a
        class="notice__link"
        href="#contact"
        >Request access</a
      >
    </div>

    <!-- Header -->
    <header class="site-header">
      <div class="container header__inner">
        <a
          class="brand"
          href="/"
        >
          <img
            src="img/logo.svg"
            alt="ASGARD PHARMA"
            class="brand__logo"
          />
          <span class="brand__name">ASGARD PHARMA</span>
        </a>

        <!-- Mobile nav toggle (no JS) -->
        <input
          type="checkbox"
          id="nav-toggle"
          class="nav-toggle"
          aria-label="Toggle navigation"
        />
        <label
          class="nav-toggle__btn"
          for="nav-toggle"
          aria-hidden="true"
        >
          <span></span><span></span><span></span>
        </label>

        <nav class="nav">
          <ul class="nav__list">
            <li><a href="#specialties">Specialties</a></li>
            <li><a href="#features">Platform</a></li>
            <li><a href="#proof">Outcomes</a></li>
            <li><a href="#contact">Contact</a></li>
          </ul>
          <div class="nav__cta">
            <a
              class="btn btn--ghost"
              href="#demo"
              >Book a demo</a
            >
            <a
              class="btn btn--primary"
              href="#contact"
              >Get started</a
            >
          </div>
        </nav>
      </div>
    </header>

    <!-- Hero -->
    <section class="hero">
      <div class="container hero__inner">
        <div class="hero__copy">
          <h1>Fabless Biologics & Vaccine Manufacturing</h1>
          <p class="lead">
            Produce <span class="highlight">affordable</span> pharmaceuticals through licensing global innovations and
            utilizing Canadian biomanufacturing infrastructure.
          </p>
          <div class="hero__actions">
            <a
              class="btn btn--primary"
              href="#contact"
              >Request access</a
            >
            <a
              class="btn btn--ghost"
              href="#features"
              >Explore the platform</a
            >
          </div>
        </div>
      </div>
    </section>

    <!-- Our Mission -->
    <section
      id="mission"
      class="section section--alt reveal"
    >
      <div class="container mission">
        <header class="section__head">
          <h2>About Us</h2>
          <p class="mission__text">
            Since 2024, Asgard Pharmaceuticals is a Canadian venture focused on licensing innovative vaccines and
            biologic therapeutics developed abroad, and bringing them to market in Canada. Our mission is to delivery
            affordable vaccines and biologics to Canadians by leveraging domestic manufacturing capabilities and AI
            systems.
            <br /><br />
            We aim to challenge the dominance of foreign multinationals and "Big Pharma" by reducing the burden of high
            cost vaccines on the taxpayer. The COVID-19 pandemic highlighted the decades-long decline in Canada's
            domestic biopharmaceutical capacity, creating a critical need to rebuild our national self-sufficiency in
            this vital sector. By reinvesting in Canada's national healthcare sovereignty, our vision is to become
            Canada's first agile, cost-efficient bridge for licensing, developing, and commercializing foreign
            intellectual property innovations.
          </p>
        </header>

        <div class="cards cards--grid-2">
          <article class="card">
            <h3 class="card__title">ðŸ’° Affordability</h3>
            <p class="card__text">
              We aim to challenge the dominance of US
              <span class="highlight">"Big Pharma"</span>
              by reducing the burden of high cost vaccines & biologics on the Canadian taxpayer through leveraging
              domestic manufacturing capabilities.
            </p>
          </article>

          <article class="card">
            <h3 class="card__title">ðŸŽ¯ Our vision</h3>
            <p class="card__text">
              Become Canada's first agile, cost-efficient bridge for licensing, developing, and commercializing
              innovative foreign intellectual property in large molecule pharmaceuticals.
            </p>
          </article>
        </div>
      </div>
    </section>

    <!-- History -->
    <section
      id="history"
      class="section section--alt reveal"
    >
      <header class="section__head">
        <h2>History</h2>
        <p>Canada was <strong class="highlight">once a leader</strong> in public vaccine manufacturing</p>
      </header>
      <div class="container history">
        <!-- Left: Text -->
        <div class="history__content">
          <ul class="history__points">
            <li>
              <span class="bullet">âž¤</span>
              In 1914, Connaught Labs produced antitoxins as a
              <strong class="highlight">public, not-for-profit institute</strong>
              tied to the University of Toronto
            </li>
            <li>
              <span class="bullet">âž¤</span>
              But by the 1990s,
              <strong class="highlight">privatization and foreign acquisitions</strong>
              (Connaught â†’ Sanofi, Armand Frappier â†’ GSK) dismantled our domestic capacity, leaving Canada
              <strong class="highlight">exposed</strong>
              during COVID 19
            </li>
            <li>
              <span class="bullet">âž¤</span>
              In response, the federal government invested $1.2B in the Biologics Manufacturing Centre (BMC) â€” which
              today
              <strong class="highlight">exposed</strong>
              , with only one confirmed partner
            </li>
          </ul>
        </div>

        <!-- Right: Images -->
        <div class="history__gallery">
          <div class="history__grid">
            <img
              src="img/history/history1.png"
              alt="History 1"
            />

            <img
              src="img/history/history3.png"
              alt="History 3"
            />
            <img
              src="img/history/history4.png"
              alt="History 4"
            />
            <img
              src="img/history/history2.png"
              alt="History 2"
            />
          </div>
        </div>
      </div>
    </section>

    <!-- Problems highlights -->
    <section
      id="problems"
      class="section section--alt reveal"
    >
      <div class="container">
        <header class="section__head">
          <h2>Problem</h2>
          <p>Essential medicines in Canada are expensive, delayed, and dangerously dependent on foreign control.</p>
        </header>

        <div class="featuresFour">
          <div class="featureProblem">
            <h3>Cost</h3>
            <p>
              Even with public and private coverage, patients still pay high out-of-pocket costsâ€”while taxpayers foot
              inflated bills driven by pharma pricing power.
            </p>
          </div>
          <div class="featureProblem">
            <h3>Fragile Health Sovereignty</h3>
            <p>Canada relies on foreign pharma giants, with little control over supply, pricing, or production.</p>
          </div>
          <div class="featureProblem">
            <h3>Vulnerable Supply Chains</h3>
            <p>
              Pandemics and geopolitics have exposed our inability to produce critical medicines when it matters most.
            </p>
          </div>
          <div class="featureProblem">
            <h3>Innovation Bottleneck</h3>
            <p>
              Cutting-edge therapies abroad are delayed or unavailable in Canada due to lack of domestic licensing and
              trial pathways.
            </p>
          </div>
        </div>
      </div>
    </section>

    <!-- Solution highlights -->
    <section
      id="solutions"
      class="section section--alt reveal"
    >
      <div class="container">
        <header class="section__head">
          <h2>Solution</h2>
        </header>

        <div class="featuresFour">
          <div class="featureSolution">
            <h3>Rebuild Domestic Biotech</h3>
            <p>
              License late-phase global innovations and invest in Canadian-led development and commercialization,
              building a resilient domestic pipeline.
            </p>
          </div>
          <div class="featureSolution">
            <h3>Deploy Idle Capacity</h3>
            <p>Facilities like the Biologics Manufacturing Centre (BMC) represent untapped national capacity.</p>
          </div>
          <div class="featureSolution">
            <h3>Slash Patient & Public Costs</h3>
            <p>
              Avoid traditional R&D overhead and global distribution markups to offer affordable, locally made biologics
              for both patients and healthcare systems.
            </p>
          </div>
          <div class="featureSolution">
            <h3>Eliminate Price Gouging</h3>
            <p>
              Minimizing cost allows minimizing excessive markups to patients while still offering high-quality
              medicines.
            </p>
          </div>
        </div>
      </div>
    </section>

    <!-- Outcomes / proof -->
    <section
      id="proof"
      class="section section--alt reveal"
    >
      <div class="container proof">
        <div class="proof__stat">
          <div class="stat__value">-32%</div>
          <div class="stat__label">no-show rate</div>
        </div>
        <div class="proof__stat">
          <div class="stat__value">+18%</div>
          <div class="stat__label">throughput</div>
        </div>
        <div class="proof__stat">
          <div class="stat__value">95%</div>
          <div class="stat__label">patient satisfaction</div>
        </div>
      </div>
    </section>

    <!-- CTA -->
    <section
      id="demo"
      class="cta reveal"
    >
      <div class="container cta__inner">
        <h2>See it in action</h2>
        <p>Get a personalized walkthrough for your specialty.</p>
        <a
          class="btn btn--primary btn--lg"
          href="#contact"
          >Book a demo</a
        >
      </div>
    </section>

    <!-- Footer -->
    <footer class="site-footer reveal">
      <div class="container footer__grid">
        <div class="footer__brand">
          <img
            src="img/logo.svg"
            alt=""
            class="brand__logo brand__logo--sm"
          />
          <p>Employing Domestic Supply Chains to Build Healthcare Resilience</p>
        </div>
        <nav class="footer__nav">
          <h4>Product</h4>
          <ul>
            <li><a href="#features">Platform</a></li>
            <li><a href="#specialties">Specialties</a></li>
            <li><a href="#proof">Outcomes</a></li>
          </ul>
        </nav>
        <nav class="footer__nav">
          <h4>Company</h4>
          <ul>
            <li><a href="#contact">Contact</a></li>
            <li><a href="#">Careers</a></li>
            <li><a href="#">Security</a></li>
          </ul>
        </nav>
        <div class="footer__cta">
          <h4>Stay in the loop</h4>
          <form
            class="form"
            action="#"
            method="post"
          >
            <label
              class="sr-only"
              for="email"
              >Email</label
            >
            <input
              id="email"
              type="email"
              placeholder="you@clinic.com"
              required
            />
            <button
              class="btn btn--primary"
              type="submit"
            >
              Subscribe
            </button>
          </form>
        </div>
      </div>
      <div class="container footer__legal">
        <p>Â© <span id="year"></span> ASGARD PHARMA. All rights reserved.</p>
        <ul class="legal__links">
          <li><a href="#">Privacy</a></li>
          <li><a href="#">Terms</a></li>
          <li><a href="#">Accessibility</a></li>
        </ul>
      </div>
    </footer>

    <script src="js/main.js"></script>
  </body>
</html>
